CeQur
CeQur is a medical device company that develops and manufactures wearable, injection-free insulin delivery solutions for people with diabetes.
CeQur has raised €430M across 6 funding rounds from 5 investors, most recently a Series D+ round in Jun 2026. Based in Horw, Switzerland; founded 2008; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€430M
€429,641,237
Funding rounds
6
Investors
5
distinct backers
Active since
2010-01
latest 2026-06
Funding by year
EUR raised per year · 2026 YTDCeQur — funding by year — interactive chart.
Data table
| CeQur — funding by year | |
|---|---|
| 2009 | €21M |
| 2013 | €20M |
| 2015 | €89M |
| 2021 | €97M |
| 2025 | €116M |
| 2026 | €86M |
Signals
Medium confidenceRaise-next likelihood37
base rate 53% for Series D+
- ▼ Raised very recently
- ▼ Down/flat last round
Exit likelihood13
base rate 11% (2+ rounds)
- ▲ €100M+ raised
- ▲ 6 rounds raised
- ▼ Old (18y) — past typical exit age
- ▼ No recent equity round (debt-only or quiet)
Timing: too soon vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
6 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-06-09 | Series D+ | €86M | undisclosed investors | View deal → |
| 2025-01-09 | Other | €116M | — | View deal → |
| 2021-04-14 | Series C | €97M | Credit Suisse Entrepreneur Capital,Endeavour Vision | View deal → |
| 2015-09-01 | Series C | €89M | VI Partners,Woodford Investment Management | View deal → |
| 2013-09-01 | Series B | €20M | — | View deal → |
| 2010-01-01 | Series A | €21M | VI Partners | View deal → |
Investors
5Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData